2型糖尿病の世界市場 2024-2028

2型糖尿病市場は2023-2028年に426億米ドル、予測期間中のCAGRは10.84%で成長すると予測されます。

当レポートでは、2型糖尿病市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。糖尿病有病率の上昇、肥満の有病率の上昇、ライフスタイルの変化、最近の製品承認などが市場を牽引しています。

本調査では、今後数年間の2型糖尿病市場成長を牽引する主要因の1つとして、高齢者人口の増加を挙げています。また、糖尿病に対する意識の高まりや、治療法における取り組みや技術革新の拡大も、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界2型糖尿病市場 2018-2022
• 薬剤クラス別セグメント分析 2018-2022
• 流通チャネル別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：薬剤クラス別

• 市場セグメンテーション
• 比較：薬剤クラス別
• インスリン：市場規模と予測 2023-2028
• DPP-4阻害剤：市場規模と予測 2023-2028
• GLP-1受容体作動薬：市場規模と予測 2023-2028
• SGLT-2阻害剤：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：薬剤クラス別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメンテーション
• 比較：流通チャネル別
• 小売薬局：市場規模と予測 2023-2028
• 病院薬局：市場規模と予測 2023-2028
• オンライン薬局：市場規模と予測 2023-2028
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Amgen Inc.
• AstraZeneca Plc
• Biocon Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• Glenmark Pharmaceuticals Ltd.
• Johnson and Johnson Services Inc.
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Type 2 Diabetes Market 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Drug Class - Market share 2023-2028 (%)
• Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Drug Class
• Exhibits35: Data Table on Comparison by Drug Class
• Exhibits36: Chart on Insulin - Market size and forecast 2023-2028 ($ billion)
• Exhibits37: Data Table on Insulin - Market size and forecast 2023-2028 ($ billion)
• Exhibits38: Chart on Insulin - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Insulin - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
• Exhibits41: Data Table on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
• Exhibits42: Chart on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
• Exhibits44: Chart on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
• Exhibits45: Data Table on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
• Exhibits46: Chart on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
• Exhibits47: Data Table on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
• Exhibits48: Chart on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits56: Market opportunity by Drug Class ($ billion)
• Exhibits57: Data Table on Market opportunity by Drug Class ($ billion)
• Exhibits58: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits59: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits60: Chart on Comparison by Distribution Channel
• Exhibits61: Data Table on Comparison by Distribution Channel
• Exhibits62: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits66: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits67: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits69: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits70: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits71: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits73: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits74: Market opportunity by Distribution Channel ($ billion)
• Exhibits75: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits79: Chart on Geographic comparison
• Exhibits80: Data Table on Geographic comparison
• Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits113: Chart on India - Market size and forecast 2023-2028 ($ billion)
• Exhibits114: Data Table on India - Market size and forecast 2023-2028 ($ billion)
• Exhibits115: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits116: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits117: Market opportunity By Geographical Landscape ($ billion)
• Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits119: Impact of drivers and challenges in 2023 and 2028
• Exhibits120: Overview on criticality of inputs and factors of differentiation
• Exhibits121: Overview on factors of disruption
• Exhibits122: Impact of key risks on business
• Exhibits123: Companies covered
• Exhibits124: Matrix on companies position and classification
• Exhibits125: Amgen Inc. - Overview
• Exhibits126: Amgen Inc. - Product / Service
• Exhibits127: Amgen Inc. - Key news
• Exhibits128: Amgen Inc. - Key offerings
• Exhibits129: AstraZeneca Plc - Overview
• Exhibits130: AstraZeneca Plc - Product / Service
• Exhibits131: AstraZeneca Plc - Key news
• Exhibits132: AstraZeneca Plc - Key offerings
• Exhibits133: Biocon Ltd. - Overview
• Exhibits134: Biocon Ltd. - Business segments
• Exhibits135: Biocon Ltd. - Key offerings
• Exhibits136: Biocon Ltd. - Segment focus
• Exhibits137: Boehringer Ingelheim International GmbH - Overview
• Exhibits138: Boehringer Ingelheim International GmbH - Product / Service
• Exhibits139: Boehringer Ingelheim International GmbH - Key news
• Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits141: Cadila Pharmaceuticals Ltd. - Overview
• Exhibits142: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibits143: Cadila Pharmaceuticals Ltd. - Key offerings
• Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits145: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits148: Eli Lilly and Co. - Overview
• Exhibits149: Eli Lilly and Co. - Product / Service
• Exhibits150: Eli Lilly and Co. - Key news
• Exhibits151: Eli Lilly and Co. - Key offerings
• Exhibits152: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits153: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits154: Glenmark Pharmaceuticals Ltd. - Key news
• Exhibits155: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits156: Johnson and Johnson Services Inc. - Overview
• Exhibits157: Johnson and Johnson Services Inc. - Business segments
• Exhibits158: Johnson and Johnson Services Inc. - Key news
• Exhibits159: Johnson and Johnson Services Inc. - Key offerings
• Exhibits160: Johnson and Johnson Services Inc. - Segment focus
• Exhibits161: Merck KGaA - Overview
• Exhibits162: Merck KGaA - Business segments
• Exhibits163: Merck KGaA - Key news
• Exhibits164: Merck KGaA - Key offerings
• Exhibits165: Merck KGaA - Segment focus
• Exhibits166: Novartis AG - Overview
• Exhibits167: Novartis AG - Business segments
• Exhibits168: Novartis AG - Key news
• Exhibits169: Novartis AG - Key offerings
• Exhibits170: Novartis AG - Segment focus
• Exhibits171: Novo Nordisk AS - Overview
• Exhibits172: Novo Nordisk AS - Business segments
• Exhibits173: Novo Nordisk AS - Key news
• Exhibits174: Novo Nordisk AS - Key offerings
• Exhibits175: Novo Nordisk AS - Segment focus
• Exhibits176: Pfizer Inc. - Overview
• Exhibits177: Pfizer Inc. - Product / Service
• Exhibits178: Pfizer Inc. - Key news
• Exhibits179: Pfizer Inc. - Key offerings
• Exhibits180: Sanofi SA - Overview
• Exhibits181: Sanofi SA - Business segments
• Exhibits182: Sanofi SA - Key news
• Exhibits183: Sanofi SA - Key offerings
• Exhibits184: Sanofi SA - Segment focus
• Exhibits185: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits186: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits187: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits188: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits189: Inclusions checklist
• Exhibits190: Exclusions checklist
• Exhibits191: Currency conversion rates for US$
• Exhibits192: Research methodology
• Exhibits193: Information sources
• Exhibits194: Data validation
• Exhibits195: Validation techniques employed for market sizing
• Exhibits196: Data synthesis
• Exhibits197: 360 degree market analysis
• Exhibits198: List of abbreviations

The type 2 diabetes market is forecasted to grow by USD 42.6 bn during 2023-2028, accelerating at a CAGR of 10.84% during the forecast period. The report on the type 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of diabetes, rise in prevalence of obesity and changing lifestyles, and recent product approvals.

Technavio's type 2 diabetes market is segmented as below:

By Drug Class

• Insulin
• DPP-4 inhibitor
• GLP-1 receptor agonists
• SGLT-2 inhibitors
• Others

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing geriatric population as one of the prime reasons driving the type 2 diabetes market growth during the next few years. Also, increase in awareness of diabetes and growing initiatives and innovations in therapies will lead to sizable demand in the market.

The report on the type 2 diabetes market covers the following areas:

• Type 2 diabetes market sizing
• Type 2 diabetes market forecast
• Type 2 diabetes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading type 2 diabetes market vendors that include Amgen Inc., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Daiichi Sankyo Co. Ltd., DM Pharma Marketing Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Practo Technologies Pvt. Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the type 2 diabetes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Type 2 Diabetes Market 2018 - 2022
  • Historic Market Size - Data Table on Global Type 2 Diabetes Market 2018 - 2022 ($ billion)
• 4.2 Drug Class segment analysis 2018 - 2022
  • Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class

• 6.1 Market segments
  • Chart on Drug Class - Market share 2023-2028 (%)
  • Data Table on Drug Class - Market share 2023-2028 (%)
• 6.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 6.3 Insulin - Market size and forecast 2023-2028
  • Chart on Insulin - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Insulin - Market size and forecast 2023-2028 ($ billion)
  • Chart on Insulin - Year-over-year growth 2023-2028 (%)
  • Data Table on Insulin - Year-over-year growth 2023-2028 (%)
• 6.4 DPP-4 inhibitor - Market size and forecast 2023-2028
  • Chart on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
  • Data Table on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
  • Chart on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
  • Data Table on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
• 6.5 GLP-1 receptor agonists - Market size and forecast 2023-2028
  • Chart on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
  • Data Table on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
  • Chart on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
  • Data Table on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
• 6.6 SGLT-2 inhibitors - Market size and forecast 2023-2028
  • Chart on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Data Table on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Chart on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
  • Data Table on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ billion)
  • Data Table on Market opportunity by Drug Class ($ billion)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Retail pharmacies - Market size and forecast 2023-2028
  • Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• 7.4 Hospital pharmacies - Market size and forecast 2023-2028
  • Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• 7.5 Online pharmacies - Market size and forecast 2023-2028
  • Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ billion)
  • Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
• 12.4 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 12.5 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
• 12.6 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
• 12.7 Cadila Pharmaceuticals Ltd.
  • Cadila Pharmaceuticals Ltd. - Overview
  • Cadila Pharmaceuticals Ltd. - Product / Service
  • Cadila Pharmaceuticals Ltd. - Key offerings
• 12.8 Daiichi Sankyo Co. Ltd.
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Product / Service
  • Daiichi Sankyo Co. Ltd. - Key news
  • Daiichi Sankyo Co. Ltd. - Key offerings
• 12.9 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key news
  • Glenmark Pharmaceuticals Ltd. - Key offerings
• 12.11 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
• 12.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.14 Novo Nordisk AS
  • Novo Nordisk AS - Overview
  • Novo Nordisk AS - Business segments
  • Novo Nordisk AS - Key news
  • Novo Nordisk AS - Key offerings
  • Novo Nordisk AS - Segment focus
• 12.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.17 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
  • 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations